ENTA
Enanta Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$397.86M
P/E Ratio
—
EPS
$-3.21
Beta
1.00
52W High
$17.15
52W Low
$4.96
50-Day MA
$13.57
200-Day MA
$11.71
Dividend Yield
—
Profit Margin
-106.80%
Forward P/E
44.05
PEG Ratio
0.00
About Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | $66.98M |
| Gross Profit (TTM) | $66.98M |
| EBITDA | $-68.13M |
| Operating Margin | -60.50% |
| Return on Equity | -60.00% |
| Return on Assets | -13.50% |
| Revenue/Share (TTM) | $2.88 |
| Book Value | $4.36 |
| Price-to-Book | 3.04 |
| Price-to-Sales (TTM) | 5.94 |
| EV/Revenue | 3.831 |
| EV/EBITDA | 41.13 |
| Quarterly Earnings Growth (YoY) | -66.20% |
| Quarterly Revenue Growth (YoY) | 9.80% |
| Shares Outstanding | $29.02M |
| Float | $20.20M |
| % Insiders | 4.69% |
| % Institutions | 91.39% |
Historical Volatility
HV 10-Day
42.35%
HV 20-Day
36.85%
HV 30-Day
40.96%
HV 60-Day
50.00%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($19.86 target)
1
Strong Buy4
Buy1
HoldData last updated: 4/29/2026